171 related articles for article (PubMed ID: 27647367)
1. A new Suzuki synthesis of triphenylethylenes that inhibit aromatase and bind to estrogen receptors α and β.
Zhao LM; Jin HS; Liu J; Skaar TC; Ipe J; Lv W; Flockhart DA; Cushman M
Bioorg Med Chem; 2016 Nov; 24(21):5400-5409. PubMed ID: 27647367
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of Triphenylethylene Bisphenols as Aromatase Inhibitors That Also Modulate Estrogen Receptors.
Lv W; Liu J; Skaar TC; O'Neill E; Yu G; Flockhart DA; Cushman M
J Med Chem; 2016 Jan; 59(1):157-70. PubMed ID: 26704594
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of mixed (E,Z)-, (E)-, and (Z)-norendoxifen with dual aromatase inhibitory and estrogen receptor modulatory activities.
Lv W; Liu J; Lu D; Flockhart DA; Cushman M
J Med Chem; 2013 Jun; 56(11):4611-8. PubMed ID: 23731360
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of norendoxifen analogues with dual aromatase inhibitory and estrogen receptor modulatory activities.
Lv W; Liu J; Skaar TC; Flockhart DA; Cushman M
J Med Chem; 2015 Mar; 58(6):2623-48. PubMed ID: 25751283
[TBL] [Abstract][Full Text] [Related]
5. Discovery of a multi-target compound for estrogen receptor-positive (ER
Almeida CF; Teixeira N; Oliveira A; Augusto TV; Correia-da-Silva G; Ramos MJ; Fernandes PA; Amaral C
Biochimie; 2021 Feb; 181():65-76. PubMed ID: 33278557
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of α-methylstilbenes using an aqueous Wittig methodology and application toward the development of potent human aromatase inhibitors.
Nielsen AJ; Raez-Villanueva S; Crankshaw DJ; Holloway AC; McNulty J
Bioorg Med Chem Lett; 2019 Jun; 29(11):1395-1398. PubMed ID: 30952594
[TBL] [Abstract][Full Text] [Related]
7. Optimization of the aromatase inhibitory activities of pyridylthiazole analogues of resveratrol.
Mayhoub AS; Marler L; Kondratyuk TP; Park EJ; Pezzuto JM; Cushman M
Bioorg Med Chem; 2012 Apr; 20(7):2427-34. PubMed ID: 22386564
[TBL] [Abstract][Full Text] [Related]
8. Potent aromatase inhibitors and molecular mechanism of inhibitory action.
Kang H; Xiao X; Huang C; Yuan Y; Tang D; Dai X; Zeng X
Eur J Med Chem; 2018 Jan; 143():426-437. PubMed ID: 29202405
[TBL] [Abstract][Full Text] [Related]
9. The tamoxifen metabolite norendoxifen is a potent and selective inhibitor of aromatase (CYP19) and a potential lead compound for novel therapeutic agents.
Lu WJ; Xu C; Pei Z; Mayhoub AS; Cushman M; Flockhart DA
Breast Cancer Res Treat; 2012 May; 133(1):99-109. PubMed ID: 21814747
[TBL] [Abstract][Full Text] [Related]
10. Design, Synthesis, and Biological Evaluation of New Azole Derivatives as Potent Aromatase Inhibitors with Potential Effects against Breast Cancer.
Kalalinia F; Jouya M; Komachali AK; Aboutourabzadeh SM; Karimi G; Behravan J; Abnous K; Etemad L; Kamali H; Hadizadeh F
Anticancer Agents Med Chem; 2018; 18(7):1016-1024. PubMed ID: 29336269
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological characterization of 3-(imidazol-1-ylmethyl)piperidine sulfonamides as aromatase inhibitors.
Di Matteo M; Ammazzalorso A; Andreoli F; Caffa I; De Filippis B; Fantacuzzi M; Giampietro L; Maccallini C; Nencioni A; Parenti MD; Soncini D; Del Rio A; Amoroso R
Bioorg Med Chem Lett; 2016 Jul; 26(13):3192-3194. PubMed ID: 27161804
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of synthesized coumarin derivatives on aromatase inhibitory activity.
Yamaguchi Y; Nishizono N; Kobayashi D; Yoshimura T; Wada K; Oda K
Bioorg Med Chem Lett; 2017 Jun; 27(12):2645-2649. PubMed ID: 28512028
[TBL] [Abstract][Full Text] [Related]
13. Design and Pharmacophore Study of Triazole Analogues as Aromatase Inhibitors.
Banjare L
Anticancer Agents Med Chem; 2024; 24(4):288-303. PubMed ID: 37921212
[TBL] [Abstract][Full Text] [Related]
14. Structure-guided identification of novel dual-targeting estrogen receptor α degraders with aromatase inhibitory activity for the treatment of endocrine-resistant breast cancer.
Xin L; Min J; Hu H; Li Y; Du C; Xie B; Cheng Y; Deng X; Deng X; Shen K; Huang J; Chen CC; Guo RT; Dong C; Zhou HB
Eur J Med Chem; 2023 May; 253():115328. PubMed ID: 37037140
[TBL] [Abstract][Full Text] [Related]
15. Ferrozoles: Ferrocenyl derivatives of letrozole with dual effects as potent aromatase inhibitors and cytostatic agents.
Diaz de Greñu B; Fernández-Aroca DM; Organero JA; Durá G; Jalón FA; Sánchez-Prieto R; Ruiz-Hidalgo MJ; Rodríguez AM; Santos L; Albasanz JL; Manzano BR
J Biol Inorg Chem; 2023 Sep; 28(6):531-547. PubMed ID: 37458856
[TBL] [Abstract][Full Text] [Related]
16. Discovery of Novel ERα and Aromatase Dual-Targeting PROTAC Degraders to Overcome Endocrine-Resistant Breast Cancer.
Xin L; Wang C; Cheng Y; Wang H; Guo X; Deng X; Deng X; Xie B; Hu H; Min C; Dong C; Zhou HB
J Med Chem; 2024 Jun; 67(11):8913-8931. PubMed ID: 38809993
[TBL] [Abstract][Full Text] [Related]
17. Lead optimization of 4-imidazolylflavans: new promising aromatase inhibitors.
Yahiaoui S; Pouget C; Buxeraud J; Chulia AJ; Fagnère C
Eur J Med Chem; 2011 Jun; 46(6):2541-5. PubMed ID: 21497425
[TBL] [Abstract][Full Text] [Related]
18. Recent Progress in the Discovery of Next Generation Inhibitors of Aromatase from the Structure-Function Perspective.
Ghosh D; Lo J; Egbuta C
J Med Chem; 2016 Jun; 59(11):5131-48. PubMed ID: 26689671
[TBL] [Abstract][Full Text] [Related]
19. Pyridine-substituted thiazolylphenol derivatives: Synthesis, modeling studies, aromatase inhibition, and antiproliferative activity evaluation.
Ertas M; Sahin Z; Berk B; Yurttas L; Biltekin SN; Demirayak S
Arch Pharm (Weinheim); 2018 Apr; 351(3-4):e1700272. PubMed ID: 29522642
[TBL] [Abstract][Full Text] [Related]
20. Novel SERMs based on 3-aryl-4-aryloxy-2H-chromen-2-one skeleton - A possible way to dual ERα/VEGFR-2 ligands for treatment of breast cancer.
Luo G; Li X; Zhang G; Wu C; Tang Z; Liu L; You Q; Xiang H
Eur J Med Chem; 2017 Nov; 140():252-273. PubMed ID: 28942113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
